Navigation Links
Lightlake Therapeutics Inc. Chief Executive Officer Letter to Shareholders
Date:12/20/2013

lied to.  These opportunities most notably include Binge Eating Disorder, Bulimia Nervosa, and amphetamine and cocaine addiction.

Over the past year, there have been some major advancements throughout these markets.  On top of our compelling Phase II data we reported in August 2012, which demonstrated the efficacy and safety of intra-nasal naloxone for Binge Eating Disorder, the American Psychiatric Association (APA) officially added Binge Eating Disorder to the DSM-5 manual in May 2013. DSM-5 is used by clinicians and researchers to diagnose and classify mental disorders in order to improve diagnoses, treatment and research. This manual is the product of more than 10 years of effort by hundreds of international experts in all aspects of mental health.  This elevated status places an even greater importance on the clinical work we are doing as it is now an officially recognized disease state by the APA.  Over the past few months, we have continued our preparation work for our next anticipated study to be conducted in the U.S.

For Bulimia Nervosa, we expect to commence a Phase II in 2014 in partnership with King's College London.  It is important to note that because we are using an approved drug in a unique, specialized formulation, our clinical trials typically are much shorter and cost efficient than a regular biotech clinical trial.  This potentially allows us to receive regulatory approval in a faster manner and shortens our time to commercialization.

Operationally, we continue to be meticulous in managing our cash position and we are utilizing all of our resources as efficiently as possible.  Through meaningful partnerships, high level collaboration and diligent execution, we anticipate a very exciting year ahead.

In summary, 2013 was a year of great progress, which would not have been possible without the continued support of our loyal shareholders.  We look forward to continue making great s
'/>"/>

SOURCE Lightlake Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Lightlake Therapeutics Commences Two-Week Patient Trial for Treatment of Opioid Overdose with National Institute on Drug Abuse (NIDA)
2. Lightlake Therapeutics Inc. Announces Positive Final Phase II Clinical Trial Results of Binge Eating Disorder Treatment
3. Moderna Therapeutics Appoints Theo Melas-Kyriazi to Board of Directors
4. Abeona Therapeutics Closes $750,000 in Seed Round to Develop Therapies for Children Suffering from Rare Sanfilippo Diseases
5. BiOptix Continues Support of Antibody Engineering & Therapeutics Research
6. NKT Therapeutics Identifies Novel anti-iNKT Antibodies for Depleting or Activating iNKT Cells
7. Northwest Biotherapeutics to Present at the Oppenheimer 24th Annual Healthcare Conference On December 10, 2013
8. Orexigen Therapeutics, Inc. Prices Offering of $100 Million of Convertible Senior Notes
9. Intarcia Therapeutics Appoints Nancy Thornberry to Board of Directors
10. Scientists develop way to successfully give nanoparticle therapeutics orally
11. Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Dose-Ranging Field Study in Client-Owned Dogs with Osteoarthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 2015 Isagenix International, a leading global health ... three Silver, and three Bronze Stevie® Awards at the ... Chicago this month.The American Business ... program in the U.S. "Winning is ... developing leaders, cultivating talent, creating a unified team, and ...
(Date:7/1/2015)... ... 2015 , ... Apex Therapeutics announced today that company CEO, David Broecker provided ... , The presentation took place on Tuesday, June 16 and provided an update on ... for the treatment of pancreatic cancer. A copy of the company overview can ...
(Date:6/30/2015)... KYOTO, Japan , July 1, 2015 R-Japan ... Act on the Safety of Regenerative Medicine from the Ministry ... Welfare on June 29, 2015. The fact ... cell processing facility through the auditing from Pharmaceuticals and Medical ... filing the application, allows it to provide stem cell manufacturing ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... is hosting a webinar to provide advanced scientific research into new classes of ... science and energy. Touted as 'the wonder material of the 21st Century' ...
Breaking Biology Technology:Isagenix Earns Nine American Business Awards 2Isagenix Earns Nine American Business Awards 3Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2R-Japan Obtained Autologous Stem Cell Manufacturing License from the Ministry of Health, Labour and Welfare 2How Graphene–based Nanomaterials and Films Revolutionize Science Explained in July 9 Webinar Hosted by Park Systems 2How Graphene–based Nanomaterials and Films Revolutionize Science Explained in July 9 Webinar Hosted by Park Systems 3How Graphene–based Nanomaterials and Films Revolutionize Science Explained in July 9 Webinar Hosted by Park Systems 4
... China /Xinhua-PRNewswire-FirstCall/ -- China,Biologic Products, Inc. (OTC ... leading plasma-based pharmaceutical companies in the People,s ... July 8, 2008, the Company was,awarded the ... "Certification") from the Department of Foreign Trade ...
... Significant Photo Damage,- Integrated Micro Ablative Scanning Technology Optimizes Patient ... Industry,s Most ... Comprehensive Anti-Aging Solution, WESTFORD, Mass., July 17 Cynosure, ... a broad array of,light-based aesthetic treatment systems, today launched the ...
... Arno Therapeutics,Inc. (OTC Bulletin Board: ARNI), today announced ... Board has changed from "LRRI.OB" to "ARNI.OB",effective July ... Therapeutics, Inc. is a clinical-stage biopharmaceutical company,that develops ... patients. Arno,s lead compound is AR-67, a novel, ...
Cached Biology Technology:China Biologic Products Honored with the Advanced Technology Certification for Foreign-Funded Enterprises 2China Biologic Products Honored with the Advanced Technology Certification for Foreign-Funded Enterprises 3Cynosure Introduces Affirm CO2(TM) Workstation for Advanced Ablative Therapy 2Cynosure Introduces Affirm CO2(TM) Workstation for Advanced Ablative Therapy 3Cynosure Introduces Affirm CO2(TM) Workstation for Advanced Ablative Therapy 4Arno Therapeutics Announces New Ticker Symbol 2
(Date:6/17/2015)... , Deutschland und GERMANTOWN, Maryland ... Investigator ®   Produktlinie mit DNA-Tests ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... neue STR-Testkits der Produktlinie Investigator ... in den Markt eingeführt. Die neuen Kits zur Erstellung ...
(Date:6/16/2015)... 2015  With the increasing number and severity of ... concern. The recent compromise of Federal employee data ... authentication within government agencies. HYPR Corp. announced ... (OTP) authenticator, has been submitted for testing and approval ... validation for tamper proofing. The proliferation ...
(Date:6/15/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... commerce market, announces that its leading payment security technology, the ... Experience! @ NYC June 18th. Digital Experience! @ ... in technology to over 300 of the top media covering ... Pavilion in New York City from ...
Breaking Biology News(10 mins):QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 4QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 5QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 6Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 2Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 3
... EAST LANSING, Mich. Monitoring oxygen levels in ... beer and more and a professor at Michigan ... The concept of oxygen sensors isn,t new. The ... fluctuations in temperature, salinity, carbon dioxide, phosphates and biological ...
... larvae ( Chaoborus spp.) may explain a few hundred ... and fish death in Swedish lakes. Researchers at the University ... sediments to show when and how fish life disappeared from ... regions. "It is actually just like a journey ...
... Laboratories at the University of New Mexico (UNM), Brown ... technique to observe herpes simplex virus type 1 (HSV1) infections ... sore, persists in a latent form inside nerve cells. Re-activation ... with Alzheimer,s disease. Details are published in the March 31 ...
Cached Biology News:Oxygen sensor invention could benefit fisheries to breweries 2Dead midges reveal living conditions of fish 2Researchers link herpes to Alzheimer's disease 2
, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed...
Ready for formulation or direct injection into animals Provided in convenient 100, 250, 1000 and 10,000 nmol sizes HPLC purified, salt free, sterile filtered, and endotoxin tested ...
... service provides the premium quality siRNAs you ... siRNAs can be readily ordered online by ... or by providing the sense and antisense ... Silencer Validated and Silencer ...
GEL FILTRATION CAL KIT HMW, 1 EA. *Category: Gel Filtration Gels....
Biology Products: